Corporate Partners

We would like to thank our partners for their support.

A world of safe and sufficient blood is a team effort. Corporate Partners demonstrate a high level of commitment to our vision through financial support and efforts to raise awareness.

We work together with like-minded companies to share knowledge to enhance transfusion practice, and we thank them for their support:

Platinum Partners
Roche

Roche

Roche provides diagnostic tests and automation platforms used worldwide to improve the safety of blood products, increase laboratory efficiency, diagnose disease, monitor response to therapy and identify gene-based factors that may aid in treatment selection.

For more information on Roche Blood Safety Solutions, please visit the Donor Screening section of our website using the link below.

Website:
diagnostics.roche.com/global/en/products/product-category/donor-screening.html

Show lessmore

Gold Partners
Abbott

Abbott

Abbott is a globally diversified healthcare company with a central purpose to help people live their healthiest possible lives. From removing the regular pain of fingersticks as people manage their diabetes to connecting patients to doctors with real-time information monitoring their hearts, from easing chronic pain and movement disorders to testing half the world’s blood donations to ensure a healthy supply, our purpose is to make the world a better place by bringing life-changing health technologies to the people who need them. That’s our commitment to helping you live your best life.

Terumo BCT

Terumo BCT

Terumo Blood cells and technologies is a medical technology company. Their products, software and services enable customers to collect and prepare blood and cells to help treat challenging diseases and conditions. Terumo BCT employees around the world believe in the potential of blood and cells to do even more for patients than they do today.

Fresenius Kabi

Fresenius Kabi

The single focus of Fresenius Kabi TCT EMEA is to enable our Transfusion Medicine and Cell Therapies (TCT) customers to achieve their mission in the 100+ countries of the region. We are global leaders in apheresis technology for both blood component collection and extracorporeal therapies, bringing new innovations focused on donor and patient comfort.  Our expert team is dedicated to forming deep partnerships with our customers, listening to their needs and responding with innovative thinking, collaboration and a shared commitment to the donors and patients we both serve.

Grifols

Grifols

Grifols is a global healthcare company whose mission is to improve the health and well being of people around the world. They accomplish this mission by producing life-saving protein therapies for patients and by providing hospitals, pharmacies and healthcare professionals with the tools they need to deliver expert medical care.

Quotient

Quotient

With over 30 years of experience developing, manufacturing and commercializing blood-grouping reagents for the global transfusion diagnostics market, Quotient is focused on providing high quality, high value immunohematology products to hospitals and blood banks around the world. Quotient is nearing the commercialization of MosaiQ™, a next generation automation platform for transfusion diagnostics.

Immucor

Immucor

Immucor plays a role in making blood transfusions safe for patients around the world. They market a complete line of traditional immunohematology reagents and fully automated instruments as well as data management software.

Ortho Clinical Diagnostics

Ortho Clinical Diagnostics

Ortho Clinical Diagnostics provides trusted products and services to the clinical laboratory and immunohematology communities.

Bio-Rad Laboratories

Bio-Rad Laboratories

Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb) is a global leader in developing, manufacturing, and marketing a broad range of innovative products for the life science research and clinical diagnostic markets. With a focus on quality and customer service for 70 years, our products advance the discovery process and improve healthcare. Our customers are university and research institutions, hospitals, public health and commercial laboratories, biotechnology and pharmaceutical companies, as well as applied laboratories that include food safety and environmental quality. Founded in 1952, Bio-Rad is based in Hercules, California, and has a global network of operations with approximately 7,900 employees worldwide. Bio-Rad had revenues of $2.9 billion in 2021.

Bronze Partners
Biomerieux

Biomerieux

BioMérieux has been a global leader in in vitro diagnostics for more than 50 years, They have always been driven by a pioneering spirit and unrelenting commitment to improve public health worldwide. Today, in more than 150 countries through 43 subsidiaries and a large network of distributors, bioMérieux provides diagnostic solutions that improve patient health and ensure consumer safety.

Cerus

Cerus

Cerus Corporation is a biomedical products company focused in the field of blood transfusion safety. The INTERCEPT Blood System is designed to reduce the risk of transfusion-transmitted infections by inactivating a broad range of pathogens such as viruses, bacteria and parasites that may be present in donated blood. The nucleic acid targeting mechanism of action of the INTERCEPT treatment is designed to inactivate established transfusion threats, such as hepatitis B and C, HIV, West Nile virus and bacteria, as well as emerging pathogens such as Chikungunya, malaria and dengue. Cerus currently markets and sells the INTERCEPT Blood System for both platelets and plasma in the United States, Europe, the Commonwealth of Independent States, the Middle East and selected countries in other regions around the world. The INTERCEPT red blood cell system is in clinical development. 

Diasorin

Diasorin

DiaSorin is a global leader in the laboratory diagnostics market, specializing in the immunodiagnostics and molecular diagnostics segments. For over 50 years DIaSorin Group has been developing, producing and commercializing diagnostic tests, supporting clinical laboratory needs and activities, providing solutions that are reliable, innovative, fully automated and standardized.

Glycorex Transplantation

Glycorex Transplantation

Glycorex’s unique technology that bio-specifically selects and removes blood group antibodies has opened up revolutionary treatments and has been used clinically for the last 20 years to enable more than 5,000 blood group incompatible transplantations. The company’s technology to treat blood is applied in several health care settings and a new unique product variant has recently been launched designed to increase availability of blood plasma by specifically reducing the blood group antibodies in donated blood plasma – a way to make ‘universal blood plasma’. Glycosorb® has the potential to provide significant improvements in logistics and accessibility.

Sysmex

Sysmex

Sysmex Corporation is a world leader in clinical laboratory systemization and solutions, including laboratory diagnostics, laboratory automation and clinical information systems. Serving customers for more than 50 years, Sysmex focuses on technological leadership in diagnostic science and information tools that make a difference in the health of people worldwide. Its R&D efforts focus on the development of high-value-added testing and diagnostic technologies that are innovative, original and optimize individual health. Sysmex also seeks to leverage its state-of-the-art technologies for cell, gene and protein analysis. 

 

 To start a conversation about becoming a corporate partner, please contact us.